Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth M Pfarr

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Chemistry & Biology|February 27, 2013
A selective inhibitor of heme biosynthesis in endosymbiotic bacteria elicits antifilarial activity in vitroChristian S Lentz, Victoria Halls, Jeffrey S Hannam, et al.
Parasites & Vectors|November 1, 2023
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label useKenneth M Pfarr, Anna K Krome, Issraa Al-Obaidi, et al.
Parasites & Vectors|March 1, 2023
The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registrationKenneth M Pfarr, Anna K Krome, Issraa Al-Obaidi, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2017
Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)Daniel Globisch, Lisa M Eubanks, Ryan J Shirey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatmentTaniawati Supali, Yenny Djuardi, Kenneth M Pfarr, et al.
Medical Microbiology and Immunology|April 10, 2003
Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria productionAchim Hoerauf, Sabine Mand, Kerstin Fischer, et al.
Journal of Medicinal Chemistry|February 27, 2014
wALADin benzimidazoles differentially modulate the function of porphobilinogen synthase orthologsChristian S Lentz, Victoria S Halls, Jeffrey S Hannam, et al.
The Journal of Infectious Diseases|September 20, 2005
Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species)Jeffrey Gilbert, Charles K Nfon, Benjamin L Makepeace, et al.
Plos Neglected Tropical Diseases|January 5, 2018
Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse modelSabine Specht, Kenneth M Pfarr, Sandra Arriens, et al.
Antibiotics (Basel, Switzerland)|May 24, 2024
The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular <i>Chlamydia</i> and <i>Wolbachia</i> and Break the Persistence Phenotype in <i>Chlamydia</i>Iris Löckener, Lara Vanessa Behrmann, Jula Reuter, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Chemistry & Biology|February 27, 2013
A selective inhibitor of heme biosynthesis in endosymbiotic bacteria elicits antifilarial activity in vitroChristian S Lentz, Victoria Halls, Jeffrey S Hannam, et al.
Parasites & Vectors|November 1, 2023
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label useKenneth M Pfarr, Anna K Krome, Issraa Al-Obaidi, et al.
Parasites & Vectors|March 1, 2023
The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registrationKenneth M Pfarr, Anna K Krome, Issraa Al-Obaidi, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2017
Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG)Daniel Globisch, Lisa M Eubanks, Ryan J Shirey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatmentTaniawati Supali, Yenny Djuardi, Kenneth M Pfarr, et al.
Medical Microbiology and Immunology|April 10, 2003
Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria productionAchim Hoerauf, Sabine Mand, Kerstin Fischer, et al.
Journal of Medicinal Chemistry|February 27, 2014
wALADin benzimidazoles differentially modulate the function of porphobilinogen synthase orthologsChristian S Lentz, Victoria S Halls, Jeffrey S Hannam, et al.
The Journal of Infectious Diseases|September 20, 2005
Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species)Jeffrey Gilbert, Charles K Nfon, Benjamin L Makepeace, et al.
Plos Neglected Tropical Diseases|January 5, 2018
Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse modelSabine Specht, Kenneth M Pfarr, Sandra Arriens, et al.
Antibiotics (Basel, Switzerland)|May 24, 2024
The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular <i>Chlamydia</i> and <i>Wolbachia</i> and Break the Persistence Phenotype in <i>Chlamydia</i>Iris Löckener, Lara Vanessa Behrmann, Jula Reuter, et al.
Pageof 3